Policy & Regulation
Sensei Biotherapeutics changes name to Faeth Therapeutics
15 June 2026 - Clinical-stage biotechnology company Sensei Biotherapeutics Inc (Nasdaq:SNSE) announced on Monday that it has changed its corporate name to Faeth Therapeutics Inc, with its common stock...
Bayer receives FDA approval for AMBELVIST MRI contrast agent
15 June 2026 - German pharmaceutical and life sciences company Bayer AG (ETR:BAYN) (OTC:BAYRY) said on Monday that it has received US Food and Drug Administration (FDA) approval for AMBELVIST (gadoqua...
Johnson & Johnson commits over USD1bn to expand Vision manufacturing in Jacksonville
15 June 2026 - Healthcare products company Johnson & Johnson (NYSE:JNJ) on Monday announced an investment of more than USD1bn to strengthen its Vision operations in Jacksonville, Florida, expandin...
Genmab reports strong epcoritamab results in elderly newly diagnosed DLBCL patients
15 June 2026 - Danish biotechnology company Genmab A/S (CPH:GMAB) on Monday reported data from the Phase 2 EPCORE DLBCL-3 and Phase 1b/2 EPCORE NHL-2 studies showing high response rates for epcoritama...
AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer
...
Acousia Therapeutics reports positive top-line efficacy results for ACOU085 in cisplatin-induced ototoxicity
15 June 2026 - Acousia Therapeutics GmbH, a clinical-stage biotechnology company developing treatments for acute and chronic inner ear hearing loss, announced on Friday positive top-line efficacy resu...